Prophylactic HPV vaccines
- 26 January 2007
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (9) , 961-965
- https://doi.org/10.1136/jcp.2006.040568
Abstract
Two HPV L1 VLP vaccines have been developed, providing protection for at least 5 years and reducing the risk of cervical cancerKeywords
This publication has 34 references indexed in Scilit:
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Variations in the age‐specific curves of human papillomavirus prevalence in women worldwideInternational Journal of Cancer, 2006
- Chapter 2: The burden of HPV-related cancersVaccine, 2006
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLoS Medicine, 2006
- HPV vaccinesBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Condyloma in pregnancy is strongly predictive of Juvenile-Onset recurrent respiratory papillomatosisObstetrics & Gynecology, 2003
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human seraJournal of General Virology, 1994
- IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSISThe Journal of Experimental Medicine, 1937